Current price is more than the intrinsic value
Stock has been generating better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists, not a lot of promoter holding is pledged and default probability is low
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.
Customise key ratios, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
In last 3 months, mutual fund holding of the company has almost stayed constant
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 16, 2019, titled "Dr. Reddy??s announces the launch of over-the-counter, store-brand equivalent of Prevacid?? 24HR Capsules (Lansoprazole Delayed-Release Capsules USP, 15 mg) in the U.S. Market".
Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.
Final • Div/Share: ₹ 20